ARCHIVES

House Passes Cancer Bill With Mandates for NCI

This article is from The Cancer Letter archive.

Vol. 38 No. 36 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

NCI-Approved Clinical Trials

August 31, 2001

NIH Director Calls For Lifting Federal Ban on Embryonic Stem Cell Research.

March 23, 2007

OMB Restriction On Reprogramming Threatens Grants Of Three Centers, Possible Restorations

June 6, 1986

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

January 3, 1986

Letters to the Editor: Love on Mammography; Freireich, Holland On Bernard Fisher

April 15, 1994